Literature DB >> 17239316

New laser treatment approaches for benign prostatic hyperplasia.

Nathaniel M Fried1.   

Abstract

The recent introduction of higher power 100 W holmium:yttrium-aluminum-garnet (Ho:YAG) and 80 W potassium titanyl phosphate lasers for rapid incision and vaporization of the prostate has resulted in renewed interest in the use of lasers for treatment of benign prostatic hyperplasia (BPH). Although long-term studies are still lacking, short-term results demonstrate that these procedures are at least as safe and effective in relieving BPH symptoms as transurethral resection of the prostate and may provide reduced morbidity. Other laser techniques, such as interstitial laser coagulation and contact laser vaporization of the prostate, have lost popularity due to complications with increased catheterization time, irritative symptoms, and infection rates. Although Ho:YAG laser enucleation of the prostate is more difficult to learn and a slower procedure than potassium titanyl phosphate laser vaporization, the Ho:YAG laser is currently the most proven laser technique for BPH treatment. This article reviews the latest developments in laser treatment of BPH over the past 2 years and provides a view toward the future of lasers in the treatment of BPH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17239316     DOI: 10.1007/s11934-007-0020-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  25 in total

Review 1.  Interstitial laser coagulation treatment of benign prostatic hyperplasia: is it to be recommended?

Authors:  M Pilar Laguna; Gerasimos Alivizatos; Jean J M C H De La Rosette
Journal:  J Endourol       Date:  2003-10       Impact factor: 2.942

Review 2.  A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia.

Authors:  Rebecca Tooher; Peter Sutherland; Anthony Costello; Peter Gilling; Guy Rees; Guy Maddern
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

Review 3.  Current role of lasers in the treatment of benign prostatic hyperplasia (BPH).

Authors:  Rainer M Kuntz
Journal:  Eur Urol       Date:  2006-03-31       Impact factor: 20.096

4.  Photoselective vaporization of the prostate: the basel experience after 108 procedures.

Authors:  Alexander Bachmann; Robin Ruszat; Stephen Wyler; Oliver Reich; Helge H Seifert; Alexander Müller; Tullio Sulser
Journal:  Eur Urol       Date:  2005-03-02       Impact factor: 20.096

5.  Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up.

Authors:  P J Gilling; K M Kennett; M R Fraundorfer
Journal:  J Endourol       Date:  2000-11       Impact factor: 2.942

6.  KTP laser versus transurethral resection: early results of a randomized trial.

Authors:  David M Bouchier-Hayes; Paul Anderson; Scott Van Appledorn; Pat Bugeja; Anthony J Costello
Journal:  J Endourol       Date:  2006-08       Impact factor: 2.942

7.  Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients.

Authors:  Kemal Sarica; Erdal Alkan; Hüseyin Lüleci; A Ihsan Taşci
Journal:  J Endourol       Date:  2005-12       Impact factor: 2.942

8.  Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.

Authors:  Alexander Bachmann; Leander Schürch; Robin Ruszat; Stephen F Wyler; Hans-Helge Seifert; Alexander Müller; Kurt Lehmann; Tullio Sulser
Journal:  Eur Urol       Date:  2005-07-18       Impact factor: 20.096

9.  Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month follow-up of a randomized trial.

Authors:  Rainer M Kuntz; Karin Lehrich; Sascha Ahyai
Journal:  J Endourol       Date:  2004-03       Impact factor: 2.942

10.  A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).

Authors:  A H H Tan; P J Gilling; K M Kennett; C Frampton; A M Westenberg; M R Fraundorfer
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

View more
  5 in total

Review 1.  The future of lasers in urology.

Authors:  Sean A Pierre; David M Albala
Journal:  World J Urol       Date:  2007-06-14       Impact factor: 4.226

2.  Impact of 120-W 2-μm continuous wave laser vapoenucleation of the prostate on sexual function.

Authors:  Yubin Wang; Jinkai Shao; Yongning Lu; Yongan Lü; Xiaodong Li
Journal:  Lasers Med Sci       Date:  2013-07-05       Impact factor: 3.161

3.  New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1,318- and 1,470-nm diode laser device.

Authors:  Felix Wezel; Gunnar Wendt-Nordahl; Nina Huck; Thorsten Bach; Christel Weiss; Maurice Stephan Michel; Axel Häcker
Journal:  World J Urol       Date:  2009-12-25       Impact factor: 4.226

4.  Management of urinary incontinence.

Authors:  George A Demaagd; Timothy C Davenport
Journal:  P T       Date:  2012-06

5.  Re-epithelialization resulted from prostate basal cells in canine prostatic urethra may represent the ideal healing method after two-micron laser resection of the prostate.

Authors:  Ying Cao; Guang-Heng Luo; Lei Luo; Xiu-Shu Yang; Jian-Xin Hu; Hua Shi; Ping Huang; Zhao-Lin Sun; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.